Bioadaptives

What Bioadaptives does

BioAdaptives Inc. (OTC: BDPT) is a Las Vegas-based, publicly traded nutraceutical and biotechnology company that develops and markets natural, herbal-based wellness products for humans and animals. The portfolio includes Zeranovia™ and Wynovia™ (companion supplements targeting the GLP-1/GIP weight-loss drug market), Xcellara™ (a regenerative stem cell activator described as backed by double-blind placebo-controlled clinical trials), the MyndSystem™ platform (MyndMed daytime and MyndRenew nighttime cognitive formulas, both TruShield-certified for WADA and UFC anti-doping compliance), and the PawPa™ pet wellness line built on a partnership with Embark Vet Services' 400,000-sample DNA database.

The company operates a direct-to-consumer model selling exclusively through company-owned e-commerce storefronts (bioadaptives.com plus dedicated product sites such as myndsystem.com, zeranovia.com, xcellara.com, and pawpa.com), with no disclosed retail, wholesale, or third-party distribution. Pricing is product-based, with MyndSystem offering a subscription at $119.93/month against a $159.90 one-time purchase. Target segments span professional combat athletes, executives, active aging adults, GLP-1 weight-loss patients at risk of muscle wasting, and pet owners.

BioAdaptives is a micro-cap with 1–10 employees per firmographic data, a single $5,000 funding round in 2013, no disclosed revenue, and no patents or trademarks on file. Leadership comprises Chairman & CEO James Keener alongside a board that includes Mark Frissora (former CEO of Caesars Entertainment, Hertz Global Holdings, and Tenneco) and Gimhana Dissanayake. Recent milestones have centered on completing WADA/UFC certifications for the MyndSystem platform in 2025–2026 and broadening the customer base beyond the original pro-athlete origin.

Name

Bioadaptives

Legal name

BioAdaptives Inc.

Website

https://bioadaptives.com

Company type

Public

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Short description

BioAdaptives (OTC: BDPT) is a Las Vegas-based public nutraceutical company that develops and sells direct-to-consumer herbal supplements for humans and pets, including the MyndSystem cognitive platform, Zeranovia weight-loss supplement for GLP-1 patients, Xcellara stem cell activator, and PawPa pet wellness products.

Ownership category

akta.pro rank

Product category

Nutraceutical Supplements

NAICS

Food (Health) Supplement Retailers (456191), Pet and Pet Supplies Retailers (45991)

SIC

Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)

akta.pro industry

PRIMARYHLAMALAJ

Senior & Cognitive Support Supplements

Healthcare & Life Sciences/Veterinary & Animal Health/Pet Supplements & Nutraceuticals

SECONDARYHLAMALAH

Weight Management & Metabolic Support Supplements

Healthcare & Life Sciences/Veterinary & Animal Health/Pet Supplements & Nutraceuticals

SECONDARYHLAMALAN

Species-Specific Supplements (Dog/Cat/Other Companion Species)

Healthcare & Life Sciences/Veterinary & Animal Health/Pet Supplements & Nutraceuticals

SECONDARYHLAMALAM

Performance, Energy & Recovery Supplements (Active/Working Pets)

Healthcare & Life Sciences/Veterinary & Animal Health/Pet Supplements & Nutraceuticals

SECONDARYHLAMALAO

Specialty & Condition-Specific Nutraceuticals (e.g., Liver, Eye, Endocrine)

Healthcare & Life Sciences/Veterinary & Animal Health/Pet Supplements & Nutraceuticals

Keywords

• Natural herbal supplements
• Cognitive performance supplements
• Weight loss supplements
• Regenerative stem cell activator
• Pet wellness products

Headquarters

HQ city

Las Vegas

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Technology or R&D, Personnel, Infrastructure

Revenue model

1. Direct Product Sales: One-time purchase of supplement products at retail pricing for individual consumers.
2. Subscription Revenue: Recurring subscription model for MyndSystem at reduced pricing ($119.93 vs $159.90 retail) providing recurring revenue from engaged customers.
3. Human Health Supplements: Revenue from human health products including Zeranovia, Wynovia, Xcellara, and MyndSystem for weight loss, nutritional support, and cognitive enhancement.
4. Animal/Pet Health Products: Revenue from PawPa pet wellness products including Regen dog chews for joint health, energy, and anti-aging benefits.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

BioAdaptives develops, markets, and directly sells a portfolio of natural herbal-based dietary supplements through company-owned e-commerce websites. Human products include Zeranovia (weight loss complementary to GLP-1/GIP drugs), Wynovia (nutritional support during weight loss), Xcellara (clinically trialed stem cell activator), and the MyndSystem dual-phase cognitive support platform combining MyndMed (daytime) and MyndRenew (nighttime). The portfolio is rounded out by PawPa pet wellness products, including the Regen dog chew, built using AI and a 400,000+ sample canine DNA database.

Product overview

BioAdaptives® Inc. offers a diversified portfolio of natural, herbal-based wellness products for humans and animals. The human health portfolio includes: Zeranovia™ for weight loss (complementary to GLP-1 treatments); Wynovia™ for nutritional support during weight loss; Xcellara™ as a regenerative stem cell activator backed by clinical trials; and MyndSystem™ as a dual-phase cognitive support platform combining MyndMed™ (daytime performance) and MyndRenew™ (nighttime recovery) formulas. The animal health brand, PawPa™, provides pet wellness solutions leveraging AI and DNA data. Products are sourced from global ingredients and enhanced through proprietary methods, targeting general health, wellness, competitive performance, rejuvenation, pain relief, and anti-aging outcomes.

Differentiator

Problem solved

Functional benefit

Brands

• Zeranovia: Innovative natural weight loss supplement designed to work with GLP-1 and GIP weight loss treatments such as Ozempic, Wegovy, Zepbound, and Mounjaro.
• Wynovia
• Xcellara
• PawPa
• MyndSystem
• MyndMed
• MyndRenew

Products and services

• Zeranovia Natural weight loss supplement designed to complement GLP-1 and GIP weight loss treatments (Ozempic, Wegovy, Zepbound, Mounjaro); supports appetite suppression, insulin sensitivity, muscle preservation, and essential nutrient delivery for adults on these treatments.
• Wynovia Nutritional support supplement formulated to prevent drastic muscle wasting associated with GLP-1/GIP drug use and to provide proper nutritional support during caloric restriction, preserving muscle mass in food-restricted states.
• Xcellara Regenerative stem cell activator backed by double-blind placebo-controlled clinical trials; supports cellular regeneration, accelerated recovery, regenerative health, anti-aging properties, and cardiovascular support.
• PawPa Pet wellness brand leveraging predictive data, AI, and Embark Vet Services' DNA database of 400,000+ samples to create custom and mass-market pet wellness solutions; flagship Regen dog chew supports regenerative health, joint health, energy and vitality, and anti-aging benefits in senior dogs.
• MyndSystem Complete neuro-performance and repair system that combines the stimulant-free MyndMed daytime cognitive performance formula (clarity, motivation, task engagement, acetylcholine support, neuronal energy) with the MyndRenew nighttime repair formula (overnight neural repair, antioxidant defense, glutathione support, brain recovery). Both formulas are WADA/UFC TruShield Certified, making MyndSystem the first complete 24/7 cognitive performance and repair system for professional athletes and high-performing adults, sold in 30-day supplies at $159.90 one-time or $119.93 subscription.

Quantifiable outcome

• TruShield Certified status achieved for both MyndMed (August 2025) and MyndRenew (June 2026)
• +1 more outcomes

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Embark Vet ServicescoreTechnology or IntegrationEmbark Vet Services provides DNA database of over 400,000 unique samples that BioAdaptives leverages through predictive data and artificial intelligence to create custom and mass-market pet wellness solutions. This partnership enables advanced customization of PawPa pet products.

Scale indicators2 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Momentous: Momentous supplies high-end nootropic and recovery supplements with ties to professional sports teams, paralleling BioAdaptives' athlete-to-executive positioning of MyndMed/MyndRenew in the premium cognitive and recovery category.
• Mind Lab Pro: Mind Lab Pro is a premium nootropic stack sold DTC targeting cognitive performance, focus, and memory, directly competing for the same executive and biohacker buyer that BioAdaptives targets with MyndMed.
• Zesty Paws: Zesty Paws is a leading DTC pet supplement brand offering joint, skin, and senior-dog chews, the most direct competitor to BioAdaptives' PawPa Regen senior-dog chew in the pet supplements category.
• Pet Honesty: Pet Honesty sells DTC pet supplements including joint and senior-dog formulations, competing head-to-head with PawPa Regen for the same senior pet owner buyer in the online pet wellness channel.
• Athletic Greens (AG1): AG1 sells a flagship daily greens/nootropic supplement on subscription, directly competing with BioAdaptives' MyndSystem subscription model in the high-performing professional cognitive-health segment.
• Onnit Labs: Onnit sells nootropic/cognitive performance supplements (Alpha Brain, New Mood) and human performance nutrition, directly overlapping BioAdaptives' MyndSystem target customer of high-performers seeking stimulant-free cognitive support.

Broad incumbents

• Herbalife: Herbalife is a global weight-management and wellness company with a broad supplement portfolio, serving as a broad incumbent comparable to BioAdaptives' Zeranovia/Wynovia weight-loss adjacent line.
• Life Extension: Life Extension is a long-established direct-to-consumer supplement brand selling cognitive, anti-aging, and regenerative wellness products, an established DTC incumbent overlapping MyndSystem and Xcellara's anti-aging positioning.
• GNC Holdings: GNC is a mass-market nutritional supplement retailer carrying cognitive, weight management, and pet supplements, representing a broad incumbent that competes with BioAdaptives across multiple SKUs at retail.

Emerging players

• Nootopia: Nootopia is a smaller DTC nootropic startup competing in the same cognitive-performance subscription niche as MyndSystem, representing an emerging player with overlapping customer base and product philosophy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/bioadaptives-inc.

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioadaptives